PEOPLE - Compugen makes appointment:
This article was originally published in Clinica
On September 1 2005, Alex Kotzer, former vice-president of Serono (Switzerland), will become president and CEO of the genomics-based drug and diagnostic discovery firm Compugen, based in Tel Aviv, Israel. He will replace Dr Mor Amitai, who is resigning. Under Mr Kotzer the company hopes to develop its predictive research capabilities and to commercialise its discovery engines and diagnostic products.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.